Omega-3 fatty acid for schizophrenia [7] (multiple letters)

American Journal of Psychiatry

Volumn 160, Issue 1, 2003, Pages 188-189

  Horrobin, David F ^a   Fenton, Wayne S ^a   Dickerson, Faith ^a   Boronow, John ^a   Hibbeln, Joseph R ^a   Knable, Michael B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ARACHIDONIC ACID; ICOSAPENTAENOIC ACID ETHYL ESTER; OMEGA 3 FATTY ACID; PLACEBO;

CLINICAL TRIAL; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; HUMAN; LETTER; PRIORITY JOURNAL; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; TREATMENT FAILURE;

ANTIPSYCHOTIC AGENTS; DRUG THERAPY, COMBINATION; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; HUMANS; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT FAILURE;

EID: 0037223779     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.160.1.188     Document Type: Letter

References (0)